Median LCS (internal name) / eyonis LCS (trade name) (1.0) is an AI-enabled medical device from Median Technologies, listed by FDA (510(k), K251474) with a decision date of 2026-02-06. Review panel: Radiology.
| FDA submission number | K251474 |
|---|---|
| Pathway | 510(k) |
| Company | Median Technologies |
| Review panel (specialty) | Radiology |
| FDA decision date | 2026-02-06 |
| Decision | Substantially Equivalent |
| Product code | QDQ |
| Classification | Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer |
| Device class | 2 |
| Regulation number | 892.2090 |
| Review time (calendar days) | 269 |
| Applicant country | FR |
Official FDA database record · FDA AI-enabled device list
All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.